DACT2 methylation heterogeneity is associated with tumor size (P < 0.01), no association are found between DACT2 methylation heterogeneity and gender, age, tumor location, TNM stage, lymph node metastasis and extra-thyroidal extension (all P > 0.05). This evidence concerns the gene DACT2 and metastasis.